Ozuah succeeds Steven M. Safyer, MD, who is retiring after 40 years of service.
Montefiore Medicine's search for a new CEO is over, and the Bronx-based health system has chosen one of its own.
Philip O. Ozuah, MD, president of Montefiore Health System and previously served as Physician-in- Chief of the Children's Hospital at Montefiore, will take over from long-serving CEO Steven Safyer, MD, on Nov. 15.
"It will be a privilege to lead Montefiore Medicine, an organization with a clear purpose – to heal, to teach, to discover and to advance the health of the communities we serve," Ozuah said in a media release.
"Ever since first joining Montefiore in 1989, I've been inspired by our institution’s commitment to excellence. We are an organization of exceptionally talented and compassionate people."
Ozuah, a pediatrician, said an area of focus under his tenure will be "to continuing to expand inclusive access to state-of-the-art care and to furthering Montefiore's role as a global leader in healthcare and biomedical research."
Safyer, who has been with Montefiore for more than 40 years, said that with Ozuah's appointment, "I know I am leaving our institution in the best possible hands."
"I have consistently been impressed by Dr. Ozuah's strategic vision for the Montefiore Health System," Safyer said. "His appointment as CEO will guarantee a smooth transition, and I know he’ll continue to uphold the standard of excellence on which Montefiore has built its reputation."
Montefiore Medicine includes the Albert Einstein College of Medicine, 15 hospitals in the New York City and Hudson Valley area, and 200 outpatient ambulatory care sites.
“It will be a privilege to lead Montefiore Medicine, an organization with a clear purpose – to heal, to teach, to discover and to advance the health of the communities we serve.”
Philip O. Ozuah, MD
John Commins is a content specialist and online news editor for HealthLeaders, a Simplify Compliance brand.
Ozuah, a pediatrician, is currently president of Montefiore Health System.
He will take over from long-serving CEO Steven Safyer, MD, on Nov. 15.